Goodman and Recursion have formed a collaboration that is generating payments and undergoing regulatory review for drug development.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Goodman and Recursion have formed a collaboration that is generating payments and undergoing regulatory review for drug development.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Goodman
Japanese company
Nothing else this week.
-
Recursion (United States)
company in Salt Lake City, United States
Nothing else this week.
- FDA
Related events
- Zenith collaborates with Harvard researchers on clinical studies, receiving FDA clearance for the trial.
- FDA, LabCorp, and Charles River Laboratories formed a collaboration to evaluate the potential for medicine abuse.
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Both the FDA and the European Medicines Agency govern drug approval processes.